MATTHEW PABIS: Open Payments
NPI 1376981589 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$66,656 in 191 payments from 23 companies in 2025. Trend: 2023 $23,500 · 2024 $61,290 · 2025 $66,656
Speaker / faculty: $35,540Honoraria: $23,975Food & beverage: $5,668Consulting: $940Travel & lodging: $534
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 35 | $34,973 |
| Axsome Therapeutics, Inc. | 31 | $25,224 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $3,465 |
| Gilead Sciences, Inc. | 29 | $743 |
| ViiV Healthcare Company | 18 | $500 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| Lundbeck LLC | 11 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $178 |
| Janssen Pharmaceuticals, Inc | 2 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $154 |
Products named: VIVITROL, Auvelity, APRETUDE, SPRAVATO, REXULTI, TRINTELLIX, RELISTOR, FANAPT.
Industry payments across NY — which companies pay providers there.
